Fillers
Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7270.1190 (Published 11 November 2000) Cite this as: BMJ 2000;321:1190
Related articles
- This Week In The BMJ Published: 11 November 2000; BMJ 321 doi:10.1136/bmj.321.7270.0/f
- Editorial Published: 11 November 2000; BMJ 321 doi:10.1136/bmj.321.7270.1171
- Correction Published: 06 January 2001; BMJ 322 doi:
- Primary Care Published: 01 December 2005; BMJ 331 doi:10.1136/bmj.331.7528.1310
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2890
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2151
- Research Published: 25 October 2011; BMJ 343 doi:10.1136/bmj.d6423
- Primary Care Published: 05 May 2005; BMJ 330 doi:10.1136/bmj.330.7499.1059
See more
- Medicalisation of female genital mutilation is a dangerous developmentBMJ February 07, 2023, 380 p302; DOI: https://doi.org/10.1136/bmj.p302
- UK should screen for tyrosinaemia in newborn babies, committee recommendsBMJ February 02, 2023, 380 p275; DOI: https://doi.org/10.1136/bmj.p275
- Ovarian cancer: Loyalty card data could help identify cases soonerBMJ January 30, 2023, 380 p227; DOI: https://doi.org/10.1136/bmj.p227
- Maternity care: Entonox is withdrawn from some hospitals because of risk to staff from high exposureBMJ January 27, 2023, 380 p212; DOI: https://doi.org/10.1136/bmj.p212
- Maternity care has deteriorated in past five years owing to staff availability, finds regulatorBMJ January 11, 2023, 380 p77; DOI: https://doi.org/10.1136/bmj.p77
Cited by...
- Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
- Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability
- Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
- Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
- Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
- Hormonal contraception and risk of venous thromboembolism: national follow-up study
- Certain Progestins Prevent the Enhancing Effect of 17{beta}-Estradiol on NO-Mediated Inhibition of Platelet Aggregation by Endothelial Cells
- Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis
- Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
- Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis
- Venous Thrombosis: The Role of Genes, Environment, and Behavior
- Diane-35 (cyproterone acetate): safety concerns
- Female Hormones and Thrombosis
- Sex Steroids Used in Hormonal Treatment Increase Vascular Procoagulant Activity by Inducing Thrombin Receptor (PAR-1) Expression: Role of the Glucocorticoid Receptor
- Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
- Pitfalls of pharmacoepidemiology
- Pitfalls of pharmacoepidemiology
- Pitfalls of pharmacoepidemiology